BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37381728)

  • 1. Association of Rare Variants in ARSA with Parkinson's Disease.
    Senkevich K; Beletskaia M; Dworkind A; Yu E; Ahmad J; Ruskey JA; Asayesh F; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Nagornov I; Tyurin A; Miliukhina I; Timofeeva A; Emelyanov A; Trempe JF; Zakharova E; Alcalay RN; Pchelina S; Gan-Or Z
    Mov Disord; 2023 Oct; 38(10):1806-1812. PubMed ID: 37381728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of rare variants in
    Senkevich K; Beletskaia M; Dworkind A; Yu E; Ahmad J; Ruskey JA; Asayesh F; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Nagornov I; Tyurin A; Miliukhina I; Timofeeva A; Emelyanov A; Zakharova E; Alcalay RN; Pchelina S; Gan-Or Z
    medRxiv; 2023 Mar; ():. PubMed ID: 36993451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the role of ARSA in Chinese patients with Parkinson's disease.
    Pan HX; Wang YG; Zhao YW; Zeng Q; Wang Z; Fang ZH; Zhang Y; Zhou X; He RC; Xu Q; Sun QY; Tan JQ; Yan XX; Li JC; Tang BS; Guo JF
    Neurobiol Aging; 2022 Jan; 109():269-272. PubMed ID: 34531044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of arylsulfatase A (ARSA) in Chinese patients with Parkinson's disease.
    Ruan Y; Zheng R; Lin ZH; Gao T; Xue NJ; Cao J; Tian J; Zhang BR; Pu JL
    Neurosci Lett; 2020 Aug; 734():135094. PubMed ID: 32470555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma arylsulfatase A levels are associated with cognitive function in Parkinson's disease.
    Li M; Shi X; Ma J; Sun W; Wang Z; Li D; Zheng J; Zhao Z; Gu Q; Chen S
    Neurol Sci; 2022 Aug; 43(8):4753-4759. PubMed ID: 35486332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk.
    Straniero L; Rimoldi V; Monfrini E; Bonvegna S; Melistaccio G; Lake J; Soldà G; Aureli M; Shankaracharya ; Keagle P; Foroud T; Landers JE; Blauwendraat C; Zecchinelli A; Cilia R; Di Fonzo A; Pezzoli G; Duga S; Asselta R
    Mov Disord; 2022 Jun; 37(6):1202-1210. PubMed ID: 35262230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma arylsulfatase A level as a compensatory biomarker of early Parkinson's disease.
    Yoo HS; Lee JS; Chung SJ; Ye BS; Sohn YH; Lee SJ; Lee PH
    Sci Rep; 2020 Mar; 10(1):5567. PubMed ID: 32221382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.
    Lee JS; Kanai K; Suzuki M; Kim WS; Yoo HS; Fu Y; Kim DK; Jung BC; Choi M; Oh KW; Li Y; Nakatani M; Nakazato T; Sekimoto S; Funayama M; Yoshino H; Kubo SI; Nishioka K; Sakai R; Ueyama M; Mochizuki H; Lee HJ; Sardi SP; Halliday GM; Nagai Y; Lee PH; Hattori N; Lee SJ
    Brain; 2019 Sep; 142(9):2845-2859. PubMed ID: 31312839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.
    Tan MMX; Lawton MA; Jabbari E; Reynolds RH; Iwaki H; Blauwendraat C; Kanavou S; Pollard MI; Hubbard L; Malek N; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Wood NW; Williams-Gray CH; Hardy J; Nalls MA; Singleton AB; Williams NM; Ben-Shlomo Y; Hu MTM; Grosset DG; Shoai M; Morris HR
    Mov Disord; 2021 Feb; 36(2):424-433. PubMed ID: 33111402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
    Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
    Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare Variants Analysis of Lysosomal Related Genes in Early-Onset and Familial Parkinson's Disease in a Chinese Cohort.
    Chen YP; Gu XJ; Song W; Hou YB; Ou RW; Zhang LY; Liu KC; Su WM; Cao B; Wei QQ; Zhao B; Wu Y; Shang HF
    J Parkinsons Dis; 2021; 11(4):1845-1855. PubMed ID: 34250953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource.
    Iwaki H; Leonard HL; Makarious MB; Bookman M; Landin B; Vismer D; Casey B; Gibbs JR; Hernandez DG; Blauwendraat C; Vitale D; Song Y; Kumar D; Dalgard CL; Sadeghi M; Dong X; Misquitta L; Scholz SW; Scherzer CR; Nalls MA; Biswas S; Singleton AB; ; ;
    Mov Disord; 2021 Aug; 36(8):1795-1804. PubMed ID: 33960523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's Disease.
    Hopfner F; Mueller SH; Szymczak S; Junge O; Tittmann L; May S; Lohmann K; Grallert H; Lieb W; Strauch K; Müller-Nurasyid M; Berger K; Schormair B; Winkelmann J; Mollenhauer B; Trenkwalder C; Maetzler W; Berg D; Kasten M; Klein C; Höglinger GU; Gasser T; Deuschl G; Franke A; Krawczak M; Dempfle A; Kuhlenbäumer G
    Mov Disord; 2020 Jul; 35(7):1245-1248. PubMed ID: 32267580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coding and Noncoding Variation in LRRK2 and Parkinson's Disease Risk.
    Lake J; Reed X; Langston RG; Nalls MA; Gan-Or Z; Cookson MR; Singleton AB; Blauwendraat C; Leonard HL;
    Mov Disord; 2022 Jan; 37(1):95-105. PubMed ID: 34542912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARSA gene variants and Parkinson's disease.
    Fan Y; Mao CY; Dong YL; Shen S; Zhang QM; Yao DB; Liu F; Li MJ; Hu XC; Wang T; Liu YT; Liu H; Wang YL; Yuan YP; Zhang C; Yang J; Shi CH; Xu YM
    Brain; 2020 Jun; 143(6):e47. PubMed ID: 32437521
    [No Abstract]   [Full Text] [Related]  

  • 16. The burden of rare damaging variants in hereditary atypical parkinsonism genes is increased in patients with Parkinson's disease.
    Kim YJ; Lee J; Kim NY; Hong S; Cho YS; Yoon J
    Neurobiol Aging; 2021 Apr; 100():118.e5-118.e13. PubMed ID: 33423827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply: ARSA gene variants and Parkinson's disease.
    Lee SJ; Lee JS; Funayama M; Yoo HS; Lee PH; Hattori N
    Brain; 2020 Jun; 143(6):e48. PubMed ID: 32437537
    [No Abstract]   [Full Text] [Related]  

  • 18. Large-Scale Screening: Phenotypic and Mutational Spectrum in Isolated and Combined Dystonia Genes.
    Thomsen M; Marth K; Loens S; Everding J; Junker J; Borngräber F; Ott F; Jesús S; Gelderblom M; Odorfer T; Kuhlenbäumer G; Kim HJ; Schaeffer E; Becktepe J; Kasten M; Brüggemann N; Pfister R; Kollewe K; Krauss JK; Lohmann E; Hinrichs F; Berg D; Jeon B; Busch H; Altenmüller E; Mir P; Kamm C; Volkmann J; Zittel S; Ferbert A; Zeuner KE; Rolfs A; Bauer P; Kühn AA; Bäumer T; Klein C; Lohmann K
    Mov Disord; 2024 Mar; 39(3):526-538. PubMed ID: 38214203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.
    Rudakou U; Yu E; Krohn L; Ruskey JA; Asayesh F; Dauvilliers Y; Spiegelman D; Greenbaum L; Fahn S; Waters CH; Dupré N; Rouleau GA; Hassin-Baer S; Fon EA; Alcalay RN; Gan-Or Z
    Brain; 2021 Mar; 144(2):462-472. PubMed ID: 33349842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication assessment of NUS1 variants in Parkinson's disease.
    Bustos BI; Bandres-Ciga S; Gibbs JR; Krainc D; Mencacci NE; Gan-Or Z; Lubbe SJ;
    Neurobiol Aging; 2021 May; 101():300.e1-300.e3. PubMed ID: 33309333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.